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ABSTRACT : An Ayurvedic preparation consisting of dried ginger, black pepper, pippali and 
leadwort root fermented in cow’s urine was given internally and a paste made of several meical 
herbs including Psoralea corylifolia for external  application was tried in patients with vitiligo.  4 
out of 10 patients had relief within six months of treatment.  Three patients had relief with 
adverse reaction on the skin and other did not respond. The preparations did not have any 
adverse effect in the body as seen from haematological parameters and biochemical tests. 
Introduction 
Vitiligo is an acquired disfiguring 
pigmentary anomaly of the skin manifested 
by depigmented white patches surrounded 
by a normal or hyper-pigmented border. The 
most commonly affected areas are face, 
upper part of the chest, dorsal aspects of 
hand, axilla,  groins,  eyes, mouth, ears, 
nipples, genetial organs, anus, elbows and 
knees (1).  It affects all races but more 
predominant in tropics. Pathogenesis of 
vitiligo has been ascribed to auto-immunity, 
heredity, neurohumors and trauma (2).  
Although spontaneous re-pigmentation 
occurs in 25% of the patients, vitiligo is 
seldom satisfactorily treated.  The major 
available drug is trimethyl psoralen (3). Use 
of hormones such as ACTH has also been 
recommended (4). In the present paper two 
Ayurvedic preparations have been clinically 
tested on 10 patients with vitiligo.  
Materials and Methods 
Patients:-  All patients undergoing the 
treatment had an onset of the disease 
between 6 months to two years.  Age of the 
patients varied from 17-60. Both male and 
females were admitted.  General health 
condition of the patients was satisfactory 
and the following biochemical and 
haematological parameters were measured 
before, during and after the treatment and 
using standard techniques (5): (a) body 
weight (b) white blood cell (WBC) count (c) 
differential count (d) haemoglobin (e) blood 
sugar (f) serum bilirubin (g) serum urea (h) 
SGPT (i) serum alkaline phosphatase.   pages  202-206 
Statistical analysis of the data was carried 
out using student’s ‘t’ test. Photographs of 
the affected areas were taken. 
Preparation of medicine for internal 
administration: All the crude drugs were 
purchased form local market and were 
identified. Dried ginger (Zingiber 
officinale)-250 gms; Black pepper  (Piper 
nigrum) 250 gms, Pippali (Piper longum) 
250 gm and Leadwort root (Plumbago 
zeylanica) 250 gms were crushed and added 
to 20 liters of Cow’s urine and fermented in 
a sealed container for 15 days. After 
fermentation it was filtered and stored in 
tightly closed bottles. 30 ml of this extract 
was mixed with 60 ml of boiled water and 
given twice daily before food. 
 
Preparation of the paste for external 
application: Physalis perviana (whole plant) 
100 gms; Calotropis gigantean (leaf) 100 
gms; Cassia fistula (leaf) 100 gms, 
Euphorbia antiquorum (stem) 100 gms, 
Psoralia corylifolia (seed) 400 gms were 
powdered and boiled in cow’s urine (2 
liters) and red sulphide of mercury (100 
gms) was added to form a fine paste.  The 
paste was dried to a powder. This powder 
was wetted with water and applied 
externally on the patches in the morning and 
exposed to sunlight for 15 minutes. 
Application of the paste was avoided in 
areas of mucous membrane. 
Booth the drugs were continued for six 
months before their effects were finally 
evaluated. Patients who had positive 
response continued using the drug and 
others were advised to change the therapy. 
Results 
All patients treated during the course of this 
study had vitiligo spread over different pants 
of the body.  Administration of the paste 
was discouraged on mucous membranes 
such as inside the lips and genitals. The drug 
given internally had a pungent odour but 
was well-tolerated by all patients.  The paste 
produced a burning sensation after exposure 
to sunlight and was not tolerated b some 
patients.  Adverse reaction including blisters 
, itching and swelling could be seen on the 
areas where the paste was applied but 
disappeared after its use was discontinued. 
Table I shows the result of the 
administration of the drug in the patients. As 
seen in the table, 6 out of 10 patients had 
positive response to the treatment evidenced 
by increased melanin formation.  However 
two of these had skin reactions.  The other 
four did not respond and one patient had 
severe skin reactions.  Photographic 
evidence of the success of the treatment is 
given in Fig.1. 
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TABLE 1 
SUMMARY OF THE EFFECT OF ADMINISTRATION OF DURGS TO VITILIGO 
PATIENTS 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
Sl. 
No 
Age & Sex  Sites  Response of treatment  
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
40,M 
18,F 
60,M 
16,M 
47,F 
21,M 
17,F 
31,M 
25,M 
34,M 
Whole body 
Lip 
Leg, Lip 
Leg, Penis 
Lip, Leg 
Neck 
Leg 
Hand, Leg 
Palms 
Penis 
Responded 
Responded, discontinued 
No respond, reaction 
Leg responded 
Not responded 
Responded 
Responds with reaction 
Responds with reaction 
No response 
No response pages  202-206 
The patients who responded to the therapy 
had vitiligo patches mainly on leg, back of 
the neck, chest and thigh whereas in 
unresponsive cases the patches were on the 
lips, genitals and palms which are usually 
more difficult to heal due to decreased 
melanosomes in this area. 
The haematological parameters of this 
patients undergoing treatment is given in 
Table II. The average hemoglobin in these 
patients did not change after 6 months of 
treatment.  The total W.B.C showed a slight 
increase (P∠0.05) suggesting that the drug 
may cause immune-stimulation.  The 
differential count did not change vey much.  
However it was found that the percentage of 
eosinophills increased to 30% in the case of 
two patients who had adverse reaction 
towards the drug indicating allergic 
manifestation. 
The biochemical parameters of the patients 
before and after treatment are shown in 
Table III. The most interesting finding is the 
significant reduction in blood sugar 
(P∠0.001). There was also a slight increase 
in serum bilirubin and serum urea (P∠0.01) 
indicating an increased hepatic function.   
However the marker enzymes of hepatic 
injury  such as alkaline phosphatase and 
SGPT did not increase. 
The administration of the drug did not have 
any appreciable change in blood pressure 
and body weight in any of the patients. 
Discussion 
The efficacy of the preparations evaluated 
by the present study has been known among 
the practitioners of ayurveda, but a 
systematic study to evaluate the claim was 
not carried out earlier.  The present report is 
therefore the first of its kind. 
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In the present report an internal drug and a 
paste for external application were prescribed 
to 10 patients with vitiligo and it was found that 
six of them had sustained positive response.   
The allergic manifestation of the paste was the 
major problem with the drug and was especially 
seen in patients who were sensitive to sunlight.  
It was found that the drug caused more reliable 
and sustained response in patients who did not 
have any reaction towards the drug. The 
internal drug was found to produce no 
remarkable change both in the haematological 
parameters and biochemical tests.   
Interestingly, eosinophils (30%) were increased 
in patients who experienced. 
TABLE 2 
Haematological parameters of vitiligo patients before and after therapy 
  Values before treatment   Values after treatment  Significance 
Haemoglobin  
Total W.B.C 
Poly 
morphoneutrophills 
Eosinophills 
Lymphocytes 
12.49 ±1.12 
8310 ± 864.6 
60.3±12.3 
 
7.6±4.7 
32.8 ± 9.75 
12.37±0.85 
9600±1358.9 
6.03±14.96 
 
9.4±13.9 
29.2±11.2 
P<0.1 
P<0.05 
P<0.1 
 
P<0.1 
P<p.1 
Values are average o ten patients 
 
TABLE 3 
Biochemical parameters of Vitiligo patients before and after therapy 
Parameters  Values before treatment   Values after treatment  Significance 
Blood sugar 
Blood urea 
Bilirubin 
SGPT 
Alkaline 
phosphatase 
114.6 ± 26.7 
17.2±5.92 
0.55±0.085 
11±8.4 
3.01±1.5 
72.4±12.49 
23.3±6.97 
0.68±0.10 
10.2±5.71 
5.1±2.96 
P<0.0001 
P<0.05 
P<0.01 
P<0.1 
P<0.1 
Values are average of ten patients  pages  202-206 
reaction.  But even in these patients both 
biochemical and haematological parameters 
were similar. 
The blood glucose  in the patients showed a 
significant decrease (P∠0.001). this may be 
mainly because of hypoglycemic effect due to 
the presence of anabolic steroids in the 
urine(6). However this needs further 
experimentation. 
The mechanism of the drug is not known at 
present.  The administration of the drug 
produced a significant increase in WBC count 
and slight increase in serumurea and bilirubin, 
indicating an increased immunostimulation and 
hepatic function.  As the marker enzymes for 
hepatic toxicity has not been significantly 
increase it could be interpreted that the drug 
does not produce any hepatotoxicity.  It is 
known that some of the  ingredients of the 
internal medication such as Piper longum 
stimulate the hepatic function (7) and hence 
may stimulate the synthesis of melanin 
precursors.  Moreover the paste has drugs with 
known free radical-producing systems like 
psoralin which may produce photo reaction 
with the melanin precursors present on the 
skin. 
Thus the effect of the formations may be due to 
increased immunostimulation, hepatic function 
and photo reaction. 
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